Related Experiment Video
Updated: Mar 16, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or
Chelsea B Polis1, Sharon J Phillips, Sharon L Hillier
1aGuttmacher Institute, New York City, New York bDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland cDepartment of Family Medicine, Boston University School of Medicine/Boston Medical Center, Boston, Massachusetts dDepartment of Obstetrics, Gynecology, and Reproductive Sciences and Magee-Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
No abstract available in PubMed .
Related Concept Videos
Birth Control Methods
Retrovirus Life Cycles
Intrauterine Drug Delivery Systems
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Sexually Transmitted Infections
Pharmacokinetics: Drug–Food and Drug–Viral Interactions

